Premium Information is available for this item - Upgrade for $1 a day
6505-01-270-5090
Usp Chlorzoxazone Tablets
6505012705090 012705090 PARAFLEX TABLETS NDC00182-1780-01
INC: 41750 Chlorzoxazone Tablets
January 2023
4
Marketplace 6505-01-270-5090
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-270-5090 5+ Documents (More...)
6505-01-289-5618 6505-01-270-5090 6505-01-264-4453 5090 6505/us 6505-01 -270 6505012705090 6505/us https
Tablets6505012705090 012705090 PARAFLEX //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-270-5090 Usp
Usp Chlorzoxazone Tablets 6505012705090 -5359 Usp https 297-3819 https// 315-5359 6505-00-023-4521
6505-01-289-5618 6505-01-270-5090 6505-01-264-4453 5090 6505/us 6505-01 -270 6505012705090 6505/us https
Usp Chlorzoxazone Tablets 6505012705090 day Upgrade your Account Upgrade 6505-01-270-5090Usp Chlorzoxazone
Tablets6505012705090 012705090 PARAFLEX //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-270-5090 Usp
Tablets 6505013155359 https//www.nsnlookup.com https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-270-5090
Usp Chlorzoxazone Tablets 6505012705090 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-270-5090
Usp Chlorzoxazone Tablets 6505012705090 day Upgrade your Account Upgrade 6505-01-270-5090Usp Chlorzoxazone
Tablets6505012705090 012705090 PARAFLEX //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-270-5090 Usp
Restrictions 6505-01-270-5090
6505-01-270-5090 is a Usp Chlorzoxazone Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-270-5090
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-270-5090
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-270-5090
- Part Number
- Manufacturer
- Status
- NDC00182-1780-01
- Manufacturer
- 63488 - Goldline Laboratories, Inc. (Active)
- Primary Buy
- Primary Buy
- PARAFLEX TABLETS
- 63488 - Goldline Laboratories, Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-270-5090
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 250.000 Milligrams Chlorzoxazone Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Special Features [FEAT]
- Scored; Peach; Round
Management Data 6505-01-270-5090
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1988
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
Similar Supply Items to 6505-01-270-5090
Freight Information 6505-01-270-5090
6505-01-270-5090 has freight characteristics.. 6505-01-270-5090 has a variance between NMFC and UFC when transported by rail and the description should be consulted.